ATLANTA, Aug. 11, 2011 /PRNewswire/ -- The seamless integration of Elekta's MOSAIQ® Oncology Information System (OIS)* and Varian's TrueBeam™ radiation therapy system is enabling the ...

MOSAIQ is a comprehensive OIS that centralizes traditional radiation oncology, particle therapy and medical oncology patient data into a single user interface, accessible by multidisciplinary teams ...

Tools developed through this investment will provide customers with innovative solutions that are fully integrated with Elekta's MOSAIQ® Oncology ... the industry's only voice-enabled electronic ...

MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities.

MosaiQ, Quotient's next-generation platform is designed to deliver fast, comprehensive antigen typing, antibody detection and disease screening results, using a single low volume sample in a high ...

QTNT has an existing revenue stream from approved reagents. However, its MosaiQ platform is its biggest potential. Despite trading at 52-week highs, QTNT has solid prospects. Looking for more ...

ATLANTA, Nov. 2, 2010 /PRNewswire/ -- Elekta's MOSAIQ® Oncology PACS has evolved to a new level with MOSAIQ Data Director, an image and data management solution for oncology professionals that ...

Quotient's MosaiQ diagnostic platform is set to be approved in the US this year. However, the stock does not seem to be drawing much investor attention. Despite having a good product and a strong ...